Activation of STAT proteins and
growth control
Jacqueline F. Bromberg
Summary
This review will discuss how STAT (
Signal Transducers
and
Activators of Transcription) proteins, a group of
transcription factors that transmit signals from the
extracellular surface of cells to the nucleus, are involved
in growth control. I will discuss the anatomy of a STAT
protein, how it works as a transcription factor, the mole-
cules that regulate its ``activity'', the phenotypes of mice
that lack individual STAT proteins and their involvement
in growth, differentiation, apoptosis, and transformation.
Finally, a number of examples will be presented of how
dysregulated STAT signaling may be involved in the
pathogenesis of cancer. BioEssays 23:161±169, 2001.
ß 2001 John Wiley & Sons, Inc.
Introduction
Over ten years ago, during work on how interferons (IFNs)
mediate activation of genes, STAT proteins were discovered,
specifically STAT1 and STAT2.
(1)
Since that time seven mam-
malian STATs and an increasing number of non-mammalian
STATs, have been isolated and shown to play important roles
in growth and development. STAT proteins are a family of
latent transcription factors that are abundantly produced in
many cell types. They become activated by phosphorylation
on a single tyrosine (at the carboxyl end of the molecule),
typically in response to extracellular ligands. An active STAT
dimer is formed through reciprocal interactions between the
SH2 domain of one monomer and the phosphorylated tyrosine
of the other.
(2)
The dimers accumulate in the nucleus,
recognize specific DNA elements in the promoters of genes
and activate transcription. Growth control and survival of
normal cells in a developing or an adult mammal are carefully
balanced. Many of the signals that influence this balance are
delivered by circulating polypeptides, whose binding to cell
surface receptors governs gene-specific transcription. Over
forty different polypeptides can mediate STAT activation
through either cytokine or G-protein receptors with associated
JAK kinases or growth factors (e.g. EGF, PDGF, CSF-1)
acting through intrinsic receptor tyrosine kinases.
(3)
In addi-
tion, numerous non-receptor tyrosine kinases (for example src
and abl) lead to STAT activation. It has been shown that
human cancer cells have often lost normal control of these
signaling systems. In addition to persistent unregulated
mitogenic signaling, the lack of suppressive signals (tumor
suppressors) is also critical in the development of cancers. In
this article, I will describe the molecular anatomy of the STAT
proteins, how they behave as transcription factors, the
mechanisms by which STAT proteins become activated and
regulated, the importance of STAT signaling in normal growth
and development and finally the role of dysregulated STAT
signaling in the pathogenesis of cancer.
STAT domains
STAT proteins were originally discovered as DNA-binding
proteins that mediate IFN signaling. We now know, however,
that they also play a central role in cytokine, growth factor, G-
protein and oncogenic tyrosine kinase signaling. Altogether,
there are seven known mammalian STAT family members.
Each is initially latent in the cytoplasm of cells (however not
necessarily as a monomer), becomes activated by phospho-
rylation on a single tyrosine residue ( 700), and dimerizes by
virtue of a reciprocal ÿ SH2 phospho-tyrosine interaction.
(1)
The dimeric STAT protein accumulates in the nucleus, binds
DNA and drives transcription. (Fig. 1). STAT proteins in the
nucleus are subsequently inactivated by tyrosine dephos-
phorylation and then return to the cytoplasm.
(4)
Determination of the three-dimensional structures of the
core of STAT1 and STAT3 (from residues 130±712; lacking
an N-terminal and C-terminal domain) bound to DNA revealed
four domains (Fig. 2).
(2)
From residues 130±320, there are
four long helical coils, which interact with each other and
provide large surfaces to interact with other proteins; residues
320±490 constitute the DNA-binding domain, a region of
BioEssays 23:161±169, ß 2001 John Wiley & Sons, Inc. BioEssays 23.2 161
Department of Medicine, Memorial Sloan-Kettering Cancer Center,
1275 York Avenue, NY 10021. E-mail: bromberj@mskcc.org
Funding agencies: McDonnell Foundation Award.
Abbreviations: CDK, Cyclin Dependent Kinase; CIS1, Cytokine
Inducible Src homology 2-domain containing protein; CSF-1, Colony
Stimulating Factor; EGF, Epidermal Growth Factor; EPO, Erythro-
poietin; FGF, Fibroblast Growth Factor; GCMSF, Granulocyte Colony
Macrophage Stimulating Factor; GR, Glucocorticoid Receptor; IFN,
Interferon; IL, Interleukin; JAB, JAK-Binding protein; JAK, Janus
Kinase; MCM, Mini-Chromosome Maintenance; MIP-1, Macrophage
Inflammatory Protein; PDGF, Platelet-Derived Growth Factor; PIAS,
Protein Inhibitors of Activated STATs; PRL, Prolactin; SH2, Src
Homology Domain; SHP, Src Homology Protein Tyrosine Phospha-
tase; SOCS, Suppressor of Cytokine Signaling; SSI, STAT-Induced
STAT-Inhibitor; STAT, Signal Transducers and Activators of Tran-
scription; TNF, Tumor Necrosis Factor.
Review articles